Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11773392 AAV treatment of Huntington's disease

Patent 11773392 was granted and assigned to University of Massachusetts on October, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
University of Massachusetts
University of Massachusetts
Date Filed
May 21, 2021
Date of Patent
October 3, 2023
Patent Applicant
University of Massachusetts
University of Massachusetts
Patent Application Number
17326400
Patent Citations
‌
US Patent 8222221 Modulation of gene expression through endogenous small RNA targeting of gene promoters
‌
US Patent 8524446 Method for detecting adeno-associated virus
‌
US Patent 8734809 AAV's and uses thereof
‌
US Patent 9217155 Isolation of novel AAV'S and uses thereof
‌
US Patent 9249424 Intranasal delivery of AAV encoding therapeutic enzymes to the central nervous system for the treatment of lysosomal storage diseases
‌
US Patent 9701984 CNS targeting AAV vectors and methods of use thereof
‌
US Patent 11046957 AAV treatment of Huntington's disease
‌
US Patent 10457940 AAV treatment of Huntington's disease
‌
US Patent 7198951 Adeno-associated virus (AAV) serotype 9 sequences, vectors containing same, and uses therefor
‌
US Patent 7235393 Method for direct rescue and amplification of integrated viruses from cellular DNA of tissues
•••
Patent Inventor Names
Neil Aronin
Edith L. Pfister
Christian Mueller
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11773392
Patent Primary Examiner
‌
Brian Whiteman

Find more entities like US Patent 11773392 AAV treatment of Huntington's disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo